Financial News Feed

Weaker Buy Today AXDX ranks #1131 as BUY CANDIDATE. Stronger Buy
Today AXDX ranks #1131 as BUY CANDIDATE.

AXDX stock Accelerate Diagnostics

AXDX stock
Accelerate Diagnostics

The primary goal for some beginner traders might be just trying to survive. Traders that are disciplined with their money management may be able to better ride out the bumps that come with inexperienc...

Read more

Accelerate Diagnosti (AXDX) shares have seen the Money Flow Indicator drop below 30, potentially spelling a near-term reversal if it crosses below the 20 line. The Money Flow Indicator is a unique ind...

Read more

Accelerate Diagnostics, Inc. (NasdaqCM:AXDX) boasts a Price to Book ratio of 18.943784. This ratio is calculated by dividing the current share price by the book value per share. Investors may use Pric...

Read more

The stock of ASLAN Pharmaceuticals Limited (NASDAQ:ASLN) is a huge mover today! The stock decreased 2.67% or $0.12 during the last trading session, reaching $4.38. About 72,039 shares traded or 165.75...

Read more

Accelerate Diagnostics Inc. (NASDAQ:AXDX) and PerkinElmer Inc. (NYSE:PKI), both competing one another are Medical Laboratories & Research companies. We will...

Read more

A recent look at ownership and volatility brings us to a 0.01970 target portfolio weight (as a decimal) for Accelerate Diagnostics, Inc. (NasdaqCM:AXDX) Target weight is the volatility adjusted recomm...

Read more

Accelerate Diagnostics Inc. (NASDAQ:AXDX) and Precipio Inc. (NASDAQ:PRPO) have been rivals in the Medical Laboratories & Research for quite some time. Below is...

Read more

Ipg Investment Advisors Llc decreased Nokia Corp Sponsored Adr (NOK) stake by 31.05% reported in 2018Q4 SEC filing. Ipg Investment Advisors Llc sold 450,511 Accelerate Diagnostics Inc (NASDAQ:AXDX) ha...

Read more

Investors might be reviewing portfolio performance over the last six months. Many investors will be tracking shares that are trading near important levels such as the 52-week high and 52-week low. Whe...

Read more

Wall Street brokerages predict that Accelerate Diagnostics Inc (NASDAQ:AXDX) will announce earnings of ($0.43) per share for the current quarter, Zacks Investment Research reports. Three analysts have...

Read more

Equities analysts expect that Accelerate Diagnostics Inc (NASDAQ:AXDX) will post earnings of ($0.43) per share for the current quarter, according to Zacks Investment Research. Three analysts have made...

Read more

Charles River Laboratories International Inc. (NYSE:CRL) and Accelerate Diagnostics Inc. (NASDAQ:AXDX) compete with each other in the Medical Laboratories &...

Read more

Trellus Management Company Llc increased Accelerate Diagnostics Inc (AXDX) stake by 406.52% reported in 2018Q4 SEC filing. Trellus Management Company Llc Gardner Lewis Asset Management LP increased In...

Read more

Since Precipio Inc. (NASDAQ:PRPO) and Accelerate Diagnostics Inc. (NASDAQ:AXDX) are part of the Medical Laboratories & Research industry, they are influenced by compare. The influences particularly af...

Read more

News Feed powered by

Proudly made at

Rise Vilnius
in partnership with
Barclays Bank